Cargando…
Safety and tolerability of Meningococcus B vaccine in patients with chronical medical conditions (CMC)
BACKGROUND: Invasive meningococcal disease is a serious global health threat in the world; in 2016, the European Centre for Disease Control and Prevention reported 3280 confirmed cases (including 304 deaths) of Invasive Meningococcal Diseases in Europe. In Italy, in 2017 were reported 200 cases 41%...
Autores principales: | Nicolosi, L., Rizzo, C., Gattinara, G. Castelli, Mirante, N., Bellelli, E., Bianchini, C., Pansini, V., Villani, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822447/ https://www.ncbi.nlm.nih.gov/pubmed/31666107 http://dx.doi.org/10.1186/s13052-019-0730-y |
Ejemplares similares
-
Meningococcus B
por: Bona, Gianni, et al.
Publicado: (2015) -
STUDIES ON MENINGOCOCCUS INFECTION : V. THE PRESENCE OF MENINGOCOCCUS PRECIPITINOGENS IN THE CEREBROSPINAL FLUID
por: Rake, Geoffrey
Publicado: (1933) -
A Note on the Agglutination of Meningococcus
por: Miller, C. Phillip
Publicado: (1944) -
Varicella associated pneumoniae in a pediatric population
por: Bozzola, Elena, et al.
Publicado: (2017) -
Genealogy of the Meningococcus and Gonococcus
Publicado: (1917)